Potential of biomarker-based enrichment strategies to identify critically ill patients for emerging cell death interventions
Cyril Willemart(University of Antwerp), Tom Vanden Berghe(University of Antwerp), Evelyne Meyer(Ghent University), Jorien De Loor(AZ Maria Middelares), Ria Roelandt(Ghent University), Mohan Rajapurkar(Muljibhai Patel Urological Hospital), Philippe G. Jorens(University of Antwerp), Yvan Saeys(HOGENT University of Applied Sciences and Arts), Dominique Benoît(Ghent University Hospital), Eric A. J. Hoste(Ghent University Hospital), Ruth Seurinck(Ghent University), Symen Ligthart(Erasmus MC), Tom Stroobants(University of Antwerp), Sze Men Choi(Ghent University), Samya Van Coillie(Ghent University)
Cited by 8
Related Papers
A comparison of single-cell trajectory inference methods
|Nature Biotechnology|2019|1.7k
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
|Nature Reviews Nephrology|2017|1.5k
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis
|Critical Care|2006|1.5k
Global epidemiology and outcomes of acute kidney injury
|Nature Reviews Nephrology|2018|1.4k
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k